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The extracellular matrix (ECM) is now appreciated as a key
regulator of cell and tissue behavior [1,2]. Support for this
notion has been derived from correlative studies demon-
strating large changes in the composition and distribution
of extracellular matrix components during tissue develop-
ment, differentiation and in response to hormone/growth
factor/cytokine influences. In addition, a variety of func-
tional studies demonstrate ECM-dependent cellular
responses in vitro while genetic approaches clearly demon-
strate critical requirements for genes encoding ECM com-
ponents or modifiers of ECM, e.g., metalloproteases, in a
wide variety of processes in vivo [3,4].
ECM produces these effects in multiple ways. One of these
is via direct interactions with cell surface ECM receptors of
various types, including integrins and syndecans. As a
result of these interactions, cytoskeletal elements are reor-
ganized which, alone, can strongly influence responses
such as apoptosis [5]. In addition, interactions with these
receptors activate a complex array of intracellular signal
transduction cascades that modulate a variety of cellular
functions including secretory activities and gene transcrip-
tion. In this regard, the ECM must be considered to act in
a continuum with the cell surface, cytoskeleton and, ulti-
mately, the nucleus. ECM also serves as a reservoir of
growth factors and cytokines. These key molecules may
bind to either polysaccharide or protein constituents of
ECM. In some cases, biochemical neutralizers of growth
factor activities, e.g., noggin [6], bind strongly to ECM.
These interactions further help limit the range of activities
of growth factors and cytokines.
In most cases, even individual ECM components are, in
fact, complexes of non-identical proteins, e.g., laminin,
collagens. These complexes normally function in the con-
text of much larger macromolecular complexes including
many other ECM components. Therefore, it is not surpris-
ing that the composition of ECM is usually quite dynamic.
This not only reflects differential expression of genes
encoding ECM components, but also various post-tran-
scriptional processes. In the cases of proteoglycans, struc-
tural nuances of the glycosaminoglycan chains are often
critical for protein binding activities. Thus, differences in
the expression or activities of glycosyltransferases and sul-
fotransferases alter the function of proteoglycans. Moreo-
ver, secreted polysaccharide-degrading enzymes may
modify these same polysaccharides after assembly into
the ECM and can release bound growth factors/cytokines.
In other examples, different isoforms of ECM polypeptide
constituents are generated either by alternative mRNA
splicing or differential expression of discrete genes encod-
ing similar proteins. Additional variety or control of func-
tion is provided by the action of secreted or cell surface-
associated metalloproteases that hydrolyze specific ECM
components at specific sites [3]. These activities can have
several consequences. New sites may be opened for the
addition of newly synthesized ECM components, the
ECM may be loosened allowing for new cell growth/pro-
liferation or migration, or growth factors/cytokines may
be released. Similar proteolytic enzymes also can act at the
cell surface to trigger release of ectodomains of ECM,
receptors, growth factor receptors or even growth factors
themselves [4].
Finally, given that most cellular responses to ECM require
engagement of cell surface receptors, factors that interfere
with cell surface receptor interactions, e.g., mucins, also
play key roles in regulating these events. Mucins also play
complex roles since they not only limit certain cell-cell,
cell-ECM interactions, but also can bind to other cell sur-
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face receptors, e.g., selectins, or, in the case of transmem-
brane mucins, interact directly with intracellular signal
transducers. As is the case for cell surface receptors, trans-
membrane mucins may be released by the action of cell
surface proteases allowing for rapid modulation of
mucin-dependent events.
In this miniseries, authors will consider the role of ECM
in reproductive processes and cancer. A select group of
topics has been chosen that, in some cases, will broadly
consider the role of ECM in a specific biological context,
i.e., prostate and prostate cancer. Other contributions will
focus on the functions of specific ECM components or
ECM receptors in particular contexts. These include the
roles of syndecans in mammary epithelia, the functions of
integrins in embryo implantation and the role of mucins
in early embryonic development and certain cancers. Col-
lectively, the reader should gain a perspective on the com-
plex regulation of ECM expression and function in
important, representative reproductive and endocrine sys-
tems.
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